CTSN PACES (A-Fib) - Clinical Trial
What is the Purpose of this Study?
We are doing this research to learn more about whether taking a blood thinner, along with medications that prevent blood clots, improve outcomes in patients who develop atrial fibrillation (irregular heartbeat) after coronary artery bypass grafting surgery.
Atrial Fibrillation (A-Fib)
Who Can Participate in the Study?
Adults who developed atrial fibrillation after coronary artery bypass grafting surgery.
What is Involved?
If you agree to be in this study, you will:
- Be randomly assigned (a fair 50/50 chance) to get the study drug or aspirin for 90 days
- Have an in-person study visit at 90 days
- Have blood tests
- Fill out questionnaires
- Have an ECGs (looks at your heart)
- Have phone up to 4 phone calls with a member of the study team
If you do not want to be part of the randomized study you may participate in a registry collecting data from your hospitalization for atrial fibrillation.